I was recently clearing out my “Downloads” folder (which had got way out of hand!), and while doing so I found a document I’d downloaded in July 2019 when I was looking into the light-sensitivity of sugammadex. It was part of an FDA review into the drug when it was being considered for approval in the United States. It just so happened this discovery came in the middle of a Twitter discussion on the potential for sugammadex to cause, amongst other things, anaphylaxis. Continue reading “Sugammadex FDA Review Documents”